Keywords: پانوبینواستات; Azacitidine; Panobinostat; Acute lymphoid leukemia; Epigenetic; Osteoblasts; Chemoprotection;
مقالات ISI پانوبینواستات (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پانوبینواستات; Acute myeloid leukemia; Azacitidine; Decitabine; Hematopoietic stem cell transplant; Maintenance therapy; Panobinostat; Sorafenib; QuizartinibAML, acute myeloid leukemia; CIBMTR, center for international blood and marrow transplant; CR, complete response;
Keywords: پانوبینواستات; Panobinostat; Marizomib; Bortezomib; Acute myeloid leukemia; Multiple myeloma
Keywords: پانوبینواستات; combination therapy; myelofibrosis; ruxolitinib; panobinostat; decitabine; LDE225; PRM-151
Keywords: پانوبینواستات; Panobinostat; Olaparib (Ola); Homologous recombination; Poly (ADP-ribose) polymerase inhibitors (PARPi); Phosphorylated histone H2AX (pH2AX); High-grade serous ovarian cancer
Metabolomic Profiling Reveals Cellular Reprogramming of B-Cell Lymphoma by a Lysine Deacetylase Inhibitor through the Choline Pathway
Keywords: پانوبینواستات; DLBCL; Metabolomics; Panobinostat; Choline pathway; PI3K;
Low expression of GFI-1 Gene is associated with Panobinostat-resistance in acute myeloid leukemia through influencing the level of HO-1
Keywords: پانوبینواستات; GFI-1; HO-1; AML; Panobinostat; Chemotherapy-resistant; Akt;
Crucial role of HO-1/IRF4-dependent apoptosis induced by panobinostat and lenalidomide in multiple myeloma
Keywords: پانوبینواستات; Multiple myeloma; Panobinostat; Heme oxygenase-1; IRF4; Lenalidomide; Apoptosis;
Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling
Keywords: پانوبینواستات; Panobinostat; Histone deacetylase inhibitors; LBH589; Non-small cell lung cancer; Epigenetic therapy;
A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF)
Keywords: پانوبینواستات; Myelofibrosis; Histone deacetylase inhibitor; Panobinostat; Epigenetics; Phase II;
Research paperEpigenetic drug combination induces remission in mouse xenograft models of pediatric acute myeloid leukemia
Keywords: پانوبینواستات; Acute myeloid leukemia; Azacitidine; Panobinostat; Epigenetics; Xenograft; Pediatric;
Cutaneous T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease
Keywords: پانوبینواستات; ARGX-110; Brentuximab vedotin; Bortezomib; Copanlisib; cutaneous T-cell lymphoma; Forodesine; Gemcitabine; HDAC inhibitors; Ipilimumab; IPH4102; Mogamulizumab; Nivolumab; NM-IL-12; Panobinostat; Pegylated liposomal doxorubicin; Pentostatin; Pralatrexate;
Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth
Keywords: پانوبینواستات; Plasmodium; Schistosoma; Leishmania; Histone deacetylase; Panobinostat;
Profiling of human epigenetic regulators using a semi-automated real-time qPCR platform validated by next generation sequencing
Keywords: پانوبینواستات; MSC; Mesenchymal stromal/stem cell; AMSC; Adipose-tissue derived mesenchymal stromal/stem cell; RT-qPCR; Real-time reverse transcriptase quantitative polymerase chain reaction; RNA-seq; RNA sequencing; EpiReg; Epigenetic regulator; HAT; Histone acetyl tra
A Phase I/II Trial of Panobinostat in Combination With Lenalidomide in Patients With Relapsed or Refractory Hodgkin Lymphoma
Keywords: پانوبینواستات; Clinical trial; Hodgkin's lymphoma; Relapsed/refractory; Lenalidomide; Panobinostat;
In vivo monitoring of the anti-angiogenic therapeutic effect of the pan-deacetylase inhibitor panobinostat by small animal PET in a mouse model of gastrointestinal cancers
Keywords: پانوبینواستات; Histone deacetylase inhibitor; Panobinostat; Colon cancer; Hepatocellular carcinoma; Positron emission tomography; RGD peptide;
Integrin-specific hydrogels as adaptable tumor organoids for malignant B and T cells
Keywords: پانوبینواستات; Lymphoma; B cell; T cell; Integrins; Hydrogels; Organoids; Panobinostat
Acetylation of intragenic histones on HPV16 correlates with enhanced HPV16 gene expression
Keywords: پانوبینواستات; HPV16; Papillomavirus; Epigenetics; Histone marks; H3K9Ac; H3K36me3; H3K9me3; H4K20me3; H2BK5me1; HDAC inhibitor; Splicing; Polyadenylation; SR proteins; Hnrnp; Panobinostat; Quisinostat;
Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression
Keywords: پانوبینواستات; Bladder cancer; Histone deacetylase inhibitor; Ku80; Panobinostat; Radiosensitisation;
Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: Results of a phase II trial
Keywords: پانوبینواستات; Cutaneous T-cell lymphoma; Panobinostat; Pan-deacetylase inhibitor; Mycosis fungoides; Sézary syndrome; Bexarotene;
A Phase II Study of the Histone Deacetylase Inhibitor Panobinostat (LBH589) in Pretreated Patients with Small-Cell Lung Cancer
Keywords: پانوبینواستات; Panobinostat; LBH58; Small-cell lung cancer; Phase II trial; Deacetylase inhibitor.
Synergistic effect of panobinostat and bortezomib on chemoresistant acute myelogenous leukemia cells via AKT and NF-κB pathways
Keywords: پانوبینواستات; Panobinostat; Bortezomib; Leukemia; AKT; NF-κB
HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA)
Keywords: پانوبینواستات; Pancreatic cancer; Panobinostat; Apoptosis; BxPC-3 cells; Xenograft tumor;
Development and validation of ultra high performance liquid chromatography–mass spectrometry method for LBH589 in mouse plasma and tissues
Keywords: پانوبینواستات; LBH589; Panobinostat; UHPLC-MS/MS; Tissue biodistribution; Bioanalysis
Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells
Keywords: پانوبینواستات; Prostate cancer; Panobinostat; HNE; Mitotic arrest; DNA damage; Androgen receptor; Free radicals
Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma
Keywords: پانوبینواستات; Reed Sternberg; Brentuximab vedotin; SGN-35; Panobinostat; HADC; Everolimus; mTOR; Rituximab
The Role of Histone Deacetylase Inhibitors in the Treatment of Patients With Cutaneous T-Cell Lymphoma
Keywords: پانوبینواستات; Belinostat; Disease burden; Epigenetics; Panobinostat; Romidepsin; Vorinostat
Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges
Keywords: پانوبینواستات; Panobinostat; LBH589; Histone deacetylase inhibitors; Pharmacodynamics; Hematologic malignancies; Solid tumors